US Patent 7691827 Amide prodrug of gemcitabine, compositions and use thereof

Patent 7691827 was granted and assigned to Eli Lilly and Company on April, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Eli Lilly

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7691827

Date of Patent

April 6, 2010

Patent Application Number

11719705

Date Filed

November 30, 2005

Patent Citations Received

‌

US Patent 11760773 Small molecule drug conjugates of gemcitabine monophosphate

Patent Primary Examiner

‌

Lawrence E Crane

Patent abstract

The present invention relates to the gemcitabine prodrug 1-(2,2-difluoro-2-deoxy-β-D -ribofuranosyl)-4-(2-propyl-1-oxopentyl)aminopyrimidin-2-one useful as an oral drug for the treatment of cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7691827 Amide prodrug of gemcitabine, compositions and use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API